Stocks and Investing
Stocks and Investing
Tue, November 9, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kristen Kluska Initiated (ADMA) at Buy and Held Target at $4.5 on, Nov 9th, 2021
Kristen Kluska of Cantor Fitzgerald, Initiated "ADMA Biologics, Inc." (ADMA) at Buy and Held Target at $4.5 on, Nov 9th, 2021.
Kristen has made no other calls on ADMA in the last 4 months.
There are 2 other peers that have a rating on ADMA. Out of the 2 peers that are also analyzing ADMA, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kristen
- Elliot Wilbur of "Raymond James" Maintained at Buy with Decreased Target to $5 on, Tuesday, October 26th, 2021
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $6 on, Thursday, August 12th, 2021
Contributing Sources